A1C reduction doesn't ensure metabolic / cardiovascular benefit. Medicine can't cure chronic disease

10 Jul 2024 · 1 min
0:57

Speaker (Dr. Ron Najafi) argues that lowering A1C alone doesn't guarantee metabolic or cardiovascular benefit and that current medicine cannot cure chronic disease because it fails to address deeper causes. He introduces the concept of the "hateful or grateful eight": eight unmeasurable subcellular pathologies with no ICD-11 codes that clinicians neither diagnose nor bill for, and which therefore remain unaddressed.

Chapters

More from Dr.

youtube.com

Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health

11mo ago
youtube.com

Robert Lustig, MD: Everything You Know About Obesity Is Wrong

11mo ago
youtube.com

What is the latest on Ozempic and Ozempic like drugs #ozempic #glp1

11mo ago
youtube.com

Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It

11mo ago
youtu.be

Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.

11mo ago
youtube.com

The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig

11mo ago
youtube.com

Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet

1y ago
youtube.com

Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome

1y ago
youtube.com

Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose

1y ago
youtube.com

Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance

1y ago
youtube.com

Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet

1y ago
See all content